I, myself, am able to wait until the meeting, I am just looking forward to read the latest and greatest news on the research world of Hep C! I'm about 98% sure that my doctor will be there.
Susan400
Wow. Maybe someone really did get into trouble. The web site where I got that info has been suspended. http://hepatitiscnewdrugresearch.com/ They had a lot of information seemingly from those abstracts. I hope it's nothing serious and things can be worked out. I really like that site. It has lots of useful information. On the other hand, maybe they are just updating themselves.
So does that mean that everything I just read this morning that was dated 10/11 was not updated yet and when will it actually be the correct updated information ?
Or did I misunderstand you ?
Hector,
That would be great if you could add me to your calendar!
peace
Hi Susie, I've been wondering how you've been..... : )
Susie is right about everything..... but..... I believe that on occasion these things get leaked.
The one point is to get people to the conferences so that they can get the latest breaking news, see the wonderful presentations (Which natap does a GREAT job of providing to us unlucky schmoes who stay home). Seems like in this day and age it is getting harder to keep the embargo in force. Information has a way of getting out.
Even trials run around these events a little. These conferences seem to be deemed appropriate places to unveil information about the performance of ones drug in trials without claims that you are either pumping your stock or deceiving people by withholding information.
I've love to be able to get into one.
willy
Uh oh. Looks like someone is gonna get into trouble.
That is the case. These abstracts are embargoed until November 5th. We have been attending AASLD meetings for the last 15 years. They are never shown to the public until the conference begins.
"Accepted abstracts are made available to the public on the AASLD website and are published in the October supplement of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting, is embargoed from release to the general public until November 5, 2011.
Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy."
Susie, according to secondary information on the web, they are available on line somewhere. I would also have thought that abstracts are just for the institution that decides whether or not to accept the presentations and is actually available only when the conference starts. However, that appears to not be the case.
http://www.thestreet.com/video/11263397/the-next-big-thing-in-biotech-hep-c-drugs.html#1191466446001
The abstracts are never printed in advance. They can be found at the NATAP site and the HCV Advocate site when the meetings begin. Right now you can see the new treatment guidelines at www.aasld.org. Those who go to the meeting will get a book that has every abstract in it.
Bump. Hector, if you are on tonight? Is it possible to get any abstracts? Supposedly they are on line somewhere. The stuff on http://hepatitiscnewdrugs.blogspot.com/search/label/AASLD%20Nov%202011
is fairly limited and not really in abstract form. There is a lot of talk about the abstracts but no actual abstracts from what I can see. Sorry. Can't wait until November :) Thank you.
Hector, I understand the abstracts have been posted. However, I can't find them anywhere on the web. Whatever is out there must be making investors pretty twitchy as the market is really reacting. Can you look and see what you can find?
http://www.thestreet.com/video/11263397/the-next-big-thing-in-biotech-hep-c-drugs.html#1191420028001
Please include me. This is great. Thanks Hector.
Best wishes to you
dointime
Hi everyone.
I put you all in my calendar for contacting when I get info from the AASLD meeting.
Please remind me when the time comes as my hepatic encephalopathy (HE) is always with me and I probably won't remember this by tomorrow . ;-)
Which is why I put it in my calendar.
Take care.
Hector
Very much appreciated Hector. Please keep us updated any way you can.
thanks for all that you do for this forum. we appreciate you. belle
Hector,
Love your knowledge and willingness to share. I look forward to what is delivered. Keep us posted.
Thanks
Vann
Hector
Any info. you can pass on would be much appreciated.
Thx in advance..
Will
I will be following the meeting as I live here in SF and my hepatologist will be presenting.
I can give links to the papers from the conference if you like or download them for you if you like.
Official Conference Coverage:
LiverLearning.org paired with our official conference coverage provider, Clinical Care Options (CCO) are the only official sources for your extended viewing of conference materials.
LiverLearning.org will premiere the 2011 Postgraduate Course, State-of-the-Art Lectures, and numerous other talks and sessions. AASLD's portal extends beyond The Liver Meeting® content -- view podcasts, slide sets and captured content from other AASLD meetings.
CCO's independent conference coverage of The Liver Meeting® includes Capsule Summaries of key presentations, as well as an Expert Analysis that focuses on key issues highlighted at the conference.
LiverLearning.org and AASLD's partnership with CCO furthers the field and fulfills our core mission to advance the science and practice of hepatology.
Also...
There will be a "HCV Symposium" on Nov. 7th - which is designed to educate the provider on newly approved and anticipated therapies for HCV and how they should be integrated into clinical practice.
On Nov. 8th there will be a "Hepatitis Debrief" Symposium which will discuss antiviral meds including new interferon free regimens.
Also AASLD will coming out with their latest updated practice guidelines for HCV including the new DAAs.
Hope this helps.
Best -
Hector